Suchen
Cryo-Cell International Inc
CCELZur Watchlist hinzufügen
3.220USD
+0.030+0.94%
Handelsschluss 07/01, 16:00（ET）Kurse um 15 Minuten verzögert
25.94MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Cryo-Cell International Inc Unternehmen
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Cryo-Cell International Inc Informationen
BörsenkürzelCCEL
Name des UnternehmensCryo-Cell International Inc
IPO-datumApr 04, 1994
CEOPortnoy (Mark L)
Anzahl der mitarbeiter82
WertpapierartOrdinary Share
GeschäftsjahresendeApr 04
Addresse700 Brooker Creek Blvd
StadtOLDSMAR
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl34677
Telefon18137492104
Websitehttps://www.cryo-cell.com/
BörsenkürzelCCEL
IPO-datumApr 04, 1994
CEOPortnoy (Mark L)
Führungskräfte von Cryo-Cell International Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+0.92%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
52.90K
+14.18%
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+0.92%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
52.90K
+14.18%
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Cryo-Cell International Inc?
Die fünf größten Anteilseigner von Cryo-Cell International Inc sind: Mr. David I. Portnoy
Wie viele Institutionen halten Anteile an Cryo-Cell International Inc (CCEL)?
Mit Stand vom 2026Q1 halten 36 Institutionen Anteile an Cryo-Cell International Inc, mit einem Gesamtmarktwert von etwa 1.00M, was 12.47% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -82390.00 gestiegen.
Was ist die größte Einnahmequelle von Cryo-Cell International Inc?
Am 2026Q1 erzielte das Geschäft mit Processing and storage fees für Cryo-Cell International Inc den höchsten Umsatz in Höhe von 31.38M, was 99.42% des Gesamtumsatzes entspricht.